Literature DB >> 21718817

Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery.

Edwin C McGee1, Umraan Ahmad, Daniel Tamez, Michael Brown, Neil Voskoboynikov, Sukit Chris Malaisrie, Richard Lee, Patrick M McCarthy.   

Abstract

HeartWare continuous flow ventricular assist devices (HVAD) configured as biventricular assist devices maintain diurnal flow variation, lead to end-organ recovery, and provide for a successful bridge-to-heart transplantation in the first successful North American use of continuous flow biventricular assist devices.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21718817     DOI: 10.1016/j.athoracsur.2011.02.081

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

2.  Transplantation in end-stage pulmonary hypertension (Third International Right Heart Failure Summit, part 3).

Authors:  Anuradha Lala
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

3.  Successful implantation of HeartWare HVAD left ventricular assist device with concomitant ascending and sinus of valsalva aneurysms repair.

Authors:  Koji Takeda; Umraan Ahmad; Sukit Chris Malaisrie; Richard Lee; Patrick M McCarthy; Edwin C McGee
Journal:  J Artif Organs       Date:  2012-02-12       Impact factor: 1.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.